Regulation of protein synthesis and the role of eIF3 in cancer

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 10, 2010, Pages 920-930

  Hershey, J W B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; eIF3; Malignant transformation; Translational control

Indexed keywords

CAP BINDING PROTEIN; CELL PROTEIN; ELONGATION FACTOR; INITIATION FACTOR 4E; MESSENGER RNA; MICRORNA; TRANS ACTING FACTOR; TRANSFER RNA;

CARCINOGENESIS; CELL PROLIFERATION; GENE OVEREXPRESSION; HUMAN; MALIGNANT TRANSFORMATION; MOLECULAR MECHANICS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; RIBOSOME;

EID: 78149240561     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2010007500098     Document Type: Review

References (60)

1. Kozak M. Emerging links between initiation of translation and human diseases. Mamm Genome 2002; 13: 401-410.
2. Scheper GC, Proud CG, van der Knaap MS. Defective translation initiation causes vanishing of cerebral white matter. Trends Mol Med 2006; 12: 159-166.
3. Ingolia NT, Ghaemmaghami S, Newman JR, Weissman JS. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profling. Science 2009; 324: 218-223.
4. Jackson RJ, Hellen CU, Pestova TV. The mechanism of eu-karyotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 2010; 11: 113-127.
5. Fraser SC. The molecular basis of translational control. Prog Mol Biol Translational Sci 2009; 90: 211-254.
6. Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009; 136: 731-745.
7. Elroy-Stein O, Merrick WC. Translation initiation via cellular internal ribosome entry sites. In: Mathews MB, Sonenberg N, Hershey JWB (Editors), Translational control in biology and medicine. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2007. p 155-172.
8. Isken O, Maquat LE. The multiple lives of NMD factors: balancing roles in gene and genome regulation. Nat Rev Genet 2008; 9: 699-712.
9. Richter JD, Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 2005; 433: 477-480.
10. Smith KE, Henshaw EC. Binding of Met-tRNAf to native 40 S ribosomal subunits in Ehrlich ascites tumor cells. J Biol Chem 1975; 250: 6880-6884.
11. LeFebvre AK, Korneeva NL, Trutschl M, Cvek U, Duzan RD, Bradley CA, et al. Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e subunit. J Biol Chem 2006; 281: 22917-22932.
12. Fraser CS, Berry KE, Hershey JW, Doudna JA. eIF3j is located in the decoding center of the human 40S ribosomal subunit. Mol Cell 2007; 26: 811-819.
13. Passmore LA, Schmeing TM, Maag D, Applefeld DJ, Acker MG, Algire MA, et al. The eukaryotic translation initiation factors eIF1 and eIF1A induce an open conformation of the 40S ribosome. Mol Cell 2007; 26: 41-50.
14. Parsyan A, Shahbazian D, Martineau Y, Petroulakis E, Alain T, Larsson O, et al. The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis. Proc Natl Acad Sci U S A 2009; 106: 22217-22222.
15. Siridechadilok B, Fraser CS, Hall RJ, Doudna JA, Nogales E. Structural roles for human translation factor eIF3 in initiation of protein synthesis. Science 2005; 310: 1513-1515.
16. Pisarev AV, Kolupaeva VG, Pisareva VP, Merrick WC, Hellen CU, Pestova TV. Specifc functional interactions of nucleotides at key -3 and +4 positions fanking the initiation codon with components of the mammalian 48S translation initiation complex. Genes Dev 2006; 20: 624-636.
17. Algire MA, Maag D, Lorsch JR. Pi release from eIF2, not GTP hydrolysis, is the step controlled by start-site selection during eukaryotic translation initiation. Mol Cell 2005; 20: 251-262.
18. Poyry TA, Kaminski A, Jackson RJ. What determines whether mammalian ribosomes resume scanning after translation of a short upstream open reading frame? Genes Dev 2004; 18: 62-75.
19. Acker MG, Lorsch JR. Mechanism of ribosomal subunit joining during eukaryotic translation initiation. Biochem Soc Trans 2008; 36: 653-657.
20. Palmiter RD. Quantitation of parameters that determine the rate of ovalbumin synthesis. Cell 1975; 4: 189-197.
21. Ron D, Harding HP. eIF2α phosphorylation in cellular stress responses and disease. In: Mathews MB, Sonenberg N, Hershey JWB (Editors), Translational control in biology and medicine. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2009. p 345-368.
22. Mahoney SJ, Dempsey JM, Blenis J. Chapter 2 Cell Signaling in Protein Synthesis Ribosome Biogenesis and Translation Initiation and Elongation. Prog Mol Biol Transl Sci 2009; 90C: 53-107.
23. Raught B, Peiretti F, Gingras AC, Livingstone M, Shahbazian D, Mayeur GL, et al. Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J 2004; 23: 1761-1769.
24. van Gorp AG, van der Vos K, Brenkman AB, Bremer A, van den Broek N, Zwartkruis F, et al. AGC kinases regulate phos-phorylation and activation of eukaryotic translation initiation factor 4B. Oncogene 2009; 28: 95-106.
25. Holz MK, Ballif BA, Gygi SP, Blenis J. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phospho-rylation events. Cell 2005; 123: 569-580.
26. Homma MK, Wada I, Suzuki T, Yamaki J, Krebs EG, Homma Y. CK2 phosphorylation of eukaryotic translation initiation factor 5 potentiates cell cycle progression. Proc Natl Acad Sci U S A 2005; 102: 15688-15693.
27. Damoc E, Fraser CS, Zhou M, Videler H, Mayeur GL, Hershey JW, et al. Structural characterization of the human eukaryotic initiation factor 3 protein complex by mass spectrometry. Mol Cell Proteomics 2007; 6: 1135-1146.
28. Shi J, Hershey JW, Nelson MA. Phosphorylation of the eukaryotic initiation factor 3f by cyclin-dependent kinase 11 during apoptosis. FEBS Lett 2009; 583: 971-977.
29. Meyuhas O, Dreazen A. Chapter 3 Ribosomal protein S6 kinase from TOP mRNAs to cell size. Prog Mol Biol Transl Sci 2009; 90C: 109-153.
30. Landry DM, Hertz MI, Thompson SR. RPS25 is essential for translation initiation by the Dicistroviridae and hepatitis C viral IRESs. Genes Dev 2009; 23: 2753-2764.
31. Ghosh A, Datta R, Majumdar A, Bhattacharya M, Datta B. The N-terminal lysine residue-rich domain II and the 340-430 amino acid segment of eukaryotic initiation factor 2-associ-ated glycoprotein p67 are the binding sites for the gamma-subunit of eIF2. Exp Cell Res 2006; 312: 3184-3203.
32. Kedersha N, Anderson P. Chapter 4 Regulation of translation by stress granules and processing bodies. Prog Mol Biol Transl Sci 2009; 90C: 155-185.
33. Hentze MW, Gebauer F, Preiss T. cis-regulatory sequences and trans-acting factors in translational control. In: Mathews MB, Sonenberg N, Hershey JWB (Editors), Translational control in biology and medicine. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2009. p 269-295.
34. Lasko P. Chapter 6 Translational control during early development. Prog Mol Biol Transl Sci 2009; 90C: 211-254.
35. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008; 9: 102-114.
36. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466: 835-840.
37. Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap. Nature 1990; 345: 544-547.
38. Fukuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H, Igarashi K. Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res 1997; 57: 5041-5044.
39. Coleman LJ, Peter MB, Teall TJ, Brannan RA, Hanby AM, Honarpisheh H, et al. Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. Br J Cancer 2009; 100: 1393-1399.
40. Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 1992; 257: 1685-1689.
41. Donze O, Jagus R, Koromilas AE, Hershey JW, Sonenberg N. Abrogation of translation initiation factor eIF-2 phospho-rylation causes malignant transformation of NIH 3T3 cells. EMBO J 1995; 14: 3828-3834.
42. Shuda M, Kondoh N, Tanaka K, Ryo A, Wakatsuki T, Hada A, et al. Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res 2000; 20: 2489-2494.
43. Lankat-Buttgereit B, Goke R. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 2009; 101: 309-317.
44. Guan XY, Fung JM, Ma NF, Lau SH, Tai LS, Xie D, et al. Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res 2004; 64: 4197-4200.
45. Anand N, Murthy S, Amann G, Wernick M, Porter LA, Cukier IH, et al. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat Genet 2002; 31: 301-305.
46. Hui DJ, Bhasker CR, Merrick WC, Sen GC. Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi. J Biol Chem 2003; 278: 39477-39482.
47. Martineau Y, Derry MC, Wang X, Yanagiya A, Berlanga JJ, Shyu AB, et al. Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation. Mol Cell Biol 2008; 28: 6658-6667.
48. Park HS, Himmelbach A, Browning KS, Hohn T, Ryabova LA. A plant viral "reinitiation" factor interacts with the host translational machinery. Cell 2001; 106: 723-733.
49. Lagirand-Cantaloube J, Offner N, Csibi A, Leibovitch MP, Batonnet-Pichon S, Tintignac LA, et al. The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy. EMBO J 2008; 27: 1266-1276.
50. Lee JP, Brauweiler A, Rudolph M, Hooper JE, Drabkin HA, Gemmill RM. The TRC8 ubiquitin ligase is sterol regulated and interacts with lipid and protein biosynthetic pathways. Mol Cancer Res 2010; 8: 93-106.
51. Bolger TA, Folkmann AW, Tran EJ, Wente SR. The mRNA export factor Gle1 and inositol hexakisphosphate regulate distinct stages of translation. Cell 2008; 134: 624-633.
52. Harris TE, Chi A, Shabanowitz J, Hunt DF, Rhoads RE, Lawrence JC Jr. mTOR-dependent stimulation of the association of eIF4G and eIF3 by insulin. EMBO J 2006; 25: 1659-1668.
53. Choy L, Derynck R. The type II transforming growth factor (TGF)-beta receptor-interacting protein TRIP-1 acts as a modulator of the TGF-beta response. J Biol Chem 1998; 273: 31455-31462.
54. Zhang L, Pan X, Hershey JW. Individual overexpression of fve subunits of human translation initiation factor eIF3 pro-motes malignant transformation of immortal fbroblast cells. J Biol Chem 2007; 282: 5790-5800.
55. Miyazaki S, Imatani A, Ballard L, Marchetti A, Buttitta F, Albertsen H, et al. The chromosome location of the human homolog of the mouse mammary tumor-associated gene INT6 and its status in human breast carcinomas. Genomics 1997; 46: 155-158.
56. Dong Z, Liu LH, Han B, Pincheira R, Zhang JT. Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth. Oncogene 2004; 23: 3790-3801.
57. Zhang L, Smit-McBride Z, Pan X, Rheinhardt J, Hershey JW. An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3. J Biol Chem 2008; 283: 24047-24060.
58. Shi J, Kahle A, Hershey JW, Honchak BM, Warneke JA, Leong SP, et al. Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells. Oncogene 2006; 25: 4923-4936.
59. Shi J, Feng Y, Goulet AC, Vaillancourt RR, Sachs NA, Hershey JW, et al. The p34cdc2-related cyclin-dependent kinase 11 interacts with the p47 subunit of eukaryotic initiation factor 3 during apoptosis. J Biol Chem 2003; 278: 5062-5071.
60. Ahlemann M, Zeidler R, Lang S, Mack B, Munz M, Gires O. Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation. Mol Carcinog 2006; 45: 957-967.